NIH trial demonstrates AI's effectiveness in opioid use disorder care

NIH trial demonstrates AI's effectiveness in opioid use disorder care

NIH-supported clinical trial shows AI tool as effective as healthcare providers in generating referrals to addiction specialists.

Study finds AI screening for OUD led to fewer hospital readmissions

The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in identifying hospitalized adults at risk for opioid use disorder and referring them to inpatient addiction specialists. When compared with patients who received consultations with providers, patients screened by AI had 47% lower odds of hospital readmission within 30 days after their initial …

The president of Farmaindustria and general director of Amgen in Spain, Fina Lladós Canela, has called for "eliminating barriers" and "creating confidence" to take advantage of the potential offered by Artificial Intelligence (IA) in the health sector, in this type of tools enable a "radical transformation".

AI screening for opioid use disorder associated with fewer hospital readmissions

An artificial intelligence (AI)-driven screening tool successfully identified hospitalized adults at risk for opioid use disorder and recommended referral to inpatient addiction specialists.